23 November 2024

Howe Street Reporter Title

Category: CBDs

  • Pubco cocaine is here: What does it mean, who’s in, and who’s real?

    Pubco cocaine is here: What does it mean, who’s in, and who’s real?

    I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl in everything?” I’d asked myself the same question many times – why kill your customers? I’d recommend you go listen because the answer is a lot…

  • Stately’s long road to public finally finds an onramp with Gold Flora/TCPO (GRAM.NEO)

    Stately’s long road to public finally finds an onramp with Gold Flora/TCPO (GRAM.NEO)

    Good things happen in sunny Costa Mesa, California and, today, one of those good things happened for a certain group of cannabis investors. Longtime readers may recall Trent Kitsch, who founded Doja Cannabis (which would be consumed by Canopy Growth Corp for $400m), had bounced to his next venture not long after that deal closed…

  • Canada’s Legal Cannabis Market: Progress, Challenges, and the Future

    Canada’s Legal Cannabis Market: Progress, Challenges, and the Future

    The legalization of the cannabis market in Canada marked a significant milestone in the country’s history. Four years after this groundbreaking event, the retail market has experienced remarkable growth, with a 122.3% annual increase in per capita stores and a 91.7% annual increase in per capita sales. There are now 3,305 cannabis stores across the…

  • Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea

    Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea

    Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene and other cannabinoid distillates into hard-pressed pills that reliably deliver accurately measured dosages with optimal bioavailability. The company’s instant release and extended-release formulations round out a…

  • Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies

    Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies

    Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid and exact dose products. “This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide…

  • To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)

    To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)

    In this episode, we take a look at a cannabis, hemp and psychedelics extraction company based in British Columbia that goes by the name Pure Extracts Technologies Corp. (PULL.C). The company offers various derivative cannabis products such as Pure Mushrooms, which are daily supplements aimed at boosting the immune system and overall health and wellness;…

  • First Glance with Jody Vance: Pure Extracts (PULL.C)

    First Glance with Jody Vance: Pure Extracts (PULL.C)

    In episode 69, Jody chats with Pure Extracts (PULL.C) CEO Ben Nikolaevsky to get an insight into the companies latest updates and plans. Pure Extracts operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts.

  • Pure Extracts Technologies (PULL.C) pushes on and shows no pandemic fatigue

    Pure Extracts Technologies (PULL.C) pushes on and shows no pandemic fatigue

    In the times of yore before COVID-19 sent us scurrying back to our caves for self-reflection and Overlook Hotel style shenanigans, the brass here at Equity Guru sent me on a mission to the snowy wastes of Pemberton, British Columbia. The company I was visiting was Pure Extracts Technologies (PULL.C), a cannabis and hemp biomass…

  • The numbers: Pure Extracts (PULL.C): Q3 sees net loss but books revenue for the first time.

    The numbers: Pure Extracts (PULL.C): Q3 sees net loss but books revenue for the first time.

    Ouch! This looks like it hurt. Pure Extracts has a market cap of $37.94 Million, is down -39.84% Year to Date, but up 24.19% in the last three months. Marketwatch has a “Buy” rating for the company. In terms of technicals, I favor the upside. Why? (Link to the full write up) – Vishal Toora…

  • Pure Extracts Technologies (PULL.C) enlists Cannavolve to widen their distribution reach

    Pure Extracts Technologies (PULL.C) enlists Cannavolve to widen their distribution reach

    Pure Extracts Technologies (PULL.C) subsidiary Pure Extracts Manufacturing pulled in an agreement with adult recreational cannabis retail sales agency, Cannavolve, today, according to a press release. Cannavolve offers a cannabis sales solution and will take care of sales in the field, including in-store product training for Pure Pulls Vapes and Pure Chews. “With approximately 2,000…